Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart

Experimental Physiology

Volumn 96, Issue 3, 2011, Pages 325-337

  Howarth, F C ^a   Qureshi, M A ^a   Hassan, Z ^a   Al Kury, L T ^a   Isaev, D ^a   Parekh, K ^a   Yammahi, S R K D ^a   Oz, M ^a   Adrian, T E ^a   Adeghate, E ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CARRIER PROTEIN; MUSCLE PROTEIN; MYOSIN HEAVY CHAIN; REGULATOR PROTEIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODING; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ELECTRIC POTENTIAL; GENE EXPRESSION; GENETIC ASSOCIATION; HEART MUSCLE; HEART VENTRICLE CONTRACTION; HEART VENTRICLE FUNCTION; HEAVY CHAIN; MUSCLE CELL; MYOFILAMENT; NONHUMAN; RAT; SARCOPLASMIC RETICULUM; UPREGULATION; ZUCKER DIABETIC FATTY RAT;

EID: 79951482601     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.055574     Document Type: Article

References (47)

1. Bassani JW, Yuan WL & Bers DM (1995). Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol Cell Physiol 37, C1313-C1319.
2. Belke DD, Swanson EA & Dillmann WH (2004). Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53, 3201-3208.
3. Bracken N, Howarth FC & Singh J (2006). Effects of streptozotocin-induced diabetes on contraction and calcium transport in rat ventricular cardiomyocytes. Ann NY Acad Sci 1084, 208-222.
4. 2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283, H1398-H1408.
5. Clark JB, Palmer CJ & Shaw WN (1983). The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173, 68-75.
6. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, Davies PJ & Taegtmeyer H (2000). Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32, 985-986.
7. Dillmann WH, Barrieux A & Shanker R (1989). Influence of thyroid hormone on myosin heavy chain mRNA and other messenger RNAs in the rat heart. Endocr Res 15, 565-577.
8. Dounis V, Siegmund T, Hansen A, Jensen J, Schumm-Draeger PM & von Bibra H (2006). Global myocardial perfusion and diastolic function are impaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease-evaluation by contrast echocardiography and pulsed tissue Doppler. Diabetologia 49, 2729-2740.
9. Feuvray D (1996). Intracellular pH control mechanisms in the diabetic myocardium. Diabetes Res Clin Pract 31(Suppl), S87-S92.
10. Forcheron F, Basset A, Del Carmine P & Beylot M (2009). Lipase maturation factor 1: its expression in Zucker diabetic rats, and effects of metformin and fenofibrate. Diabetes Metab 35, 452-457.
11. Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, Riegger GA, Kromer EP & Weil J (2004). Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 13, 11-19.
12. Giger J, Qin AX, Bodell PW, Baldwin KM & Haddad F (2007). Activity of the β-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism. Am J Physiol Heart Circ Physiol 292, H3065-H3071.
13. Fulop N, Mason MM, Dutta K, Wang P, Davidoff AJ, Marchase RB & Chatham JC (2007). Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am J Physiol Cell Physiol 292, C1370-C1378.
14. 2+ current in rat ventricular myocytes. J Physiol 516, 409-419.
15. 2+ in ventricular myocytes from the Goto-Kakizaki diabetic rat. Mol Cell Biochem 315, 69-74.
16. 2+ in streptozotocin-induced diabetic rats. Pflügers Arch 444, 446-451.
17. Julien J (1997). Cardiac complications in non-insulin-dependent diabetes mellitus. J Diabetes Complications 11, 123-130.
18. 2+ channel - regulation of CACNA1H by neuron-restrictive silencer factor. J Pharmacol Sci 99, 211-213.
19. Levi AJ, Hancox JC, Howarth FC, Croker J & Vinnicombe J (1996). A method for making rapid changes of superfusate whilst maintaining temperature at 37°C. Pflügers Arch 432, 930-937.
20. Liou YM & Chang JC (2004). Differential pH effect on calcium-induced conformational changes of cardiac troponin C complexed with cardiac and fast skeletal isoforms of troponin I and troponin T. J Biochem 136, 683-692.
21. Malhotra A & Sanghi V (1997). Regulation of contractile proteins in diabetic heart. Cardiovasc Res 34, 34-40.
22. Markuszewski L, Grycewicz T, Pietruszynski R, Michalkiewicz D & Roszczyk N (2006). [Glycosylated hemoglobin and left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus]. Pol Merkur Lekarski 21, 8-11. [Article in Polish.]
23. Marsh SA, Powell PC, Agarwal A, Dell'Italia LJ & Chatham JC (2007). Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis. Am J Physiol Heart Circ Physiol 293, H292-H298.
24. Nakao K, Minobe W, Roden R, Bristow MR & Leinwand LA (1997). Myosin heavy chain gene expression in human heart failure. J Clin Invest 100, 2362-2370.
25. 2+ channels during hypertension and Timothy syndrome. Circ Res 106, 748-756.
26. 2+ channel in murine hearts during the embryonic period. Am J Physiol Heart Circ Physiol 286, H2257-H2263.
27. i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes 55, 608-615.
28. Pontes Andersen CC, Holmstrup P, Buschard K & Flyvbjerg A (2008). Renal alterations in prediabetic rats with periodontitis. J Periodontol 79, 684-690.
29. 2+ release is prolonged in nonfailing myocardium of diabetic patients. Mol Cell Biochem 308, 141-149.
30. Schafer S, Linz W, Bube A, Gerl M, Huber J, Kurzel GU, Bleich M, Schmidts HL, Busch AE & Rutten H (2003). Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats. Cardiovasc Res 60, 447-454.
31. Schuyler GT & Yarbrough LR (1990). Effects of age on myosin and creatine kinase isoforms in left ventricles of Fischer 344 rats. Mech Ageing Dev 56, 23-38.
32. 2+ release in myocytes from streptozotocin-induced diabetic rats. J Mol Cell Cardiol 42, 234-246.
33. Sharman JE, Haluska BA, Fang ZY, Prins JB & Marwick TH (2007). Association of arterial wave properties and diastolic dysfunction in patients with type 2 diabetes mellitus. Am J Cardiol 99, 844-848.
34. Shimabukuro M, Zhou YT, Levi M & Unger RH (1998). Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 95, 2498-2502.
35. Song D, Kuo KH, Yao R, Hutchings SR & Pang CC (2008a). Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats. Eur J Pharmacol 579, 253-259.
36. Song D, Yao R & Pang CC (2008b). Altered vasodilator role of nitric oxide synthase in the pancreas, heart and brain of rats with spontaneous type 2 diabetes. Eur J Pharmacol 591, 177-181.
37. Spurgeon HA, DuBell WH, Stern MD, Sollott SJ, Ziman BD, Silverman HS, Capogrossi MC, Talo A & Lakatta EG (1992). Cytosolic calcium and myofilaments in single rat cardiac myocytes achieve a dynamic equilibrium during twitch relaxation. J Physiol 447, 83-102.
38. 2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res 105, 527-536.
39. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS & Bell GI (1995). Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44, 1447-1457.
40. Van Den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, van der Velden J, Boer C, Ouwens DM & Diamant M (2009). Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol 8, 39.
41. von Bibra H, Thrainsdottir IS, Hansen A, Dounis V, Malmberg K & Ryden L (2005). Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2, 24-30.
42. Wang P & Chatham JC (2004). Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286, E725-E736.
43. Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ & Herrero P (2006). Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study. J Nucl Med 47, 689-697.
44. Zawalich WS, Zawalich KC, Kelley GG & Shulman GI (1995). Islet phosphoinositide hydrolysis and insulin secretory responses from prediabetic fa/fa ZDF rats. Biochem Biophys Res Commun 209, 974-980.
45. Zhou BQ & Hu SJ (2005). [Alterations of myocardial ultrastructure and gene expression of calcium handling proteins in diabetic rat heart]. Zhejiang Da Xue Xue Bao Yi Xue Ban 34, 454-458. [Article in Chinese.]
46. Zhou BQ, Hu SJ & Wang GB (2006). The analysis of ultrastructure and gene expression of sarco/endoplasmic reticulum calcium handling proteins in alloxan-induced diabetic rat myocardium. Acta Cardiol 61, 21-27.
47. Zimmet PZ & Alberti KG (2006). Introduction: Globalization and the non-communicable disease epidemic. Obesity (Silver Spring) 14, 1-3.